NCT04444986View on ClinicalTrials.gov

Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 5, 2020

Primary Completion Date

June 11, 2020

Study Completion Date

June 13, 2020

Conditions
Bioequivalence
Interventions
DRUG

FAVIR 200 MG FT

FAVICOVIR containing 200 mg favipiravir manufactured by Kocak, Turkey.

DRUG

AVIGAN 200 mg FT

AVIGAN containing 200 mg favipiravir manufactured by Toyama, Japan

Trial Locations (2)

06970

Novagenix Drug R&D Center, Akyurt

Unknown

Farmagen Ar-Ge Biyot. Ltd. Sti., Gaziantep

All Listed Sponsors
collaborator

Novagenix Bioanalytical Drug R&D Center

NETWORK

collaborator

Farmagen Ar-Ge Biyot. Ltd. Sti

NETWORK

lead

Kocak Farma

INDUSTRY

NCT04444986 - Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions | Biotech Hunter | Biotech Hunter